3i Group plc

AATec Medical GmbH

AbbVie Ventures

AbbVie, Inc.

abcDNA GmbH

Abingworth LLP

ABIVAX

Accequa

Accession Therapeutics Limited

AdBio Partners

AdCab

ADOCIA

Adularia AG

Advantary Capital Partners

AEC Partners

AFK & Partners Asset Management LLC

Aixial Group

Akribion Therapeutics GmbH

Alipheron AG

Allegro N.V.

Alternative Assets Finance

Altrovia

Ampleia

Amporin Pharmaceuticals AG

AMR Action Fund GP GmbH

Anaveon AG

Andera Partners SA

Angelini Ventures S.p.A.

Apollo Health Ventures

ARCHIMED

Argenx

Argobio Studio

Asahi Kasei Europe GmbH

Astellas Pharma Europe Ltd.

AstraZeneca

Astrivax Therapeutics N.V.

AurorA Science Srl

Avance Life Sciences

Baker McKenzie

BaseLaunch

Bayern Kapital GmbH

BeOne Medicines I GmbH

BERNINA BioInvest Ltd.

BetterLife Pharma

BioMedPartners AG

BioMedVC AG

BioPharma Advisory

Bioqube Ventures

BIOSTART Consulting GmbH

biotx.ai GmbH

Biovision Ventures

Bioxodes SA

BlackRock

Blackstone Group

Bloomberg Intelligence

BNP Paribas Asset Management

Boehringer Ingelheim International GmbH

Bpifrance

Brainomix Limited

Brandon Capital Partners

Breakline Resolution

Breslin AG - LSFA - Life Science and Financing

Business Angels Switzerland

Cancer Research Horizons

Canton of Basel-Stad

Capital Grand Est

CARTemis Therapeutics GmbH

Cati Therapeutics

CDR-Life, Inc.

Cereus Biosciences

CheckBrain Therapeutics

Chugai Venture Fund, LLC

Claris Ventures

ClearideBio Therapeutics AG

Cohesion Bureau

Convergence Partners

Coulter Partners

CPTx GmbH

Cullgen Inc.

Curlim

Debiopharm International SA

Dementia Discovery Fund 2 L.P. (SV Health Investors)

Diamante Società Benefit Srl

Digital Networks PLC

Earlybird Health Management GmbH & Co. KG

Eight Bridges

Eleva GmbH

Eli Lilly and Company

Elpiscience Biopharmaceuticals Co. Ltd.

Ervimmune

ESC Advisors

European Braintech Fund

European Investment Fund

Evidenze

Evotec AG

Expert Systems, Inc.

ExpreS2ion Biotech Holding AB

F. Hoffmann-La Roche AG

F. Hoffmann-La Roche Ltd.

FastVentures B.V.

FimmCyte AG

Finanz und Wirtschaft

Fine Treatment Limited

FINNCURE Ltd.

FluoSphera SA

Fontaine Capital

Forbion

Forta Bio, Inc.

Fortlane Partners GmbH

Forty51 Ventures AG

Forvis Mazars

Fraser Partners

Fresenius Ventures

Fund+

Futurewave AG

Galimedix Therapeutics, Inc.

Generation Fund Life Sciences Fund I

Genevant Sciences GmbH

Genius Search GmbH & Co. KG

Genmab A/S

Gibela Therapeutics GmbH

GIBF

Gilde Healthcare Partners BV

Gimv

GOLDTRACK Ventures GmbH

GSK

Hansa Biopharma AB

HBM Partners AG

HealthCap

HealthCare Royalty Partners

HeartBeat.bio AG

HEPHAISTOS-Pharma

High-Tech Gründerfonds Management GmbH

Hong Kong Exchanges and Clearing Limited (HKEX)

i&i Biotech Fund I SCSp

IAMA Therapeutics S.r.l.

ICOSA Group

Industrifonden

Iniuva GmbH

Innunity Therapeutics

INOGROUP GmbH

Institute of Molecular & Clinical Ophthalmology Basel (IOB)

Intercontinental Capital

Intermediate Capital Group PLC

Inveready Asset Management S.G.E.I.C., S.A.

IPF Partners

iQure Pharma Inc.

Italian Angels for Growth (IAG)

IXICO plc

J.P. Morgan

J.P. Morgan Private Bank (Suisse) SA

Jeito Capital

JFG Life Sciences Stiftung der Universität Basel

Johnson & Johnson Innovation LLC

Kaleida Capital

Kerna Ventures

kez.biosolutions GmbH

King Bioventures

KreaMedica Holdings Inc.

Ksilink

Kurma Partners

Landmark Bioventures

Landmark BioVentures AG

Lifespan Vision Ventures LLC

LMU Munich

LongRiver Investments

Lonza Group AG

Lucera GmbH

Lynx Financial Hong Kong Ltd.

Maeve Therapeutics B.V.

Meddenovo Drug Design SAS

MedinCell S.A.

MEDiSTRAVA

Merck KGaA, Darmstadt, Germany

Mérieux Equity Partners

Micreos Pharma

Micreos Pharmaceuticals AG

MIG Capital

Mirabaud & Cie SA

Mission BioCapital

Moncyte Health

Move Venture Consulting

Mwyngil Therapeutics

Myria Biosciences AG

NatIgGs GmbH

Nerai Bioscience AG

NG Bio LTD

Noetica Pharma

Nomal Therapeutics

Novartis Pharma AG

Novo Holdings A/S

NRW.Venture

NRx Pharmaceuticals, Inc.

Nucleome Therapeutics Ltd.

Nucleus Network Ltd

NXI Therapeutics AG

NxR Biotechnologies GmbH

Oncostellae

Oppenheimer & Co. Inc.

Organon

Origenis GmbH

Oxford Science Enterprises

OxSonics

Panakès Partners SGR SpA

Paris Saclay Cancer Cluster (PSCC)

Peppermint VenturePartners GmbH

Peregrine Ventures

PharmNovo AB

Phialogics AG

Procavea Biotech AG

Pureos Bioventures

Rahim Invest SÀRL

Recordati Pharma GmbH

Redalpine Venture Partners AG

Ropes & Gray LLP

RV Invest GmbH

Salus Partners SA

Sappiens SAS

Schwarz Financial Communication

SCI Ventures LLC

Secarna Pharmaceuticals GmbH & Co. KG

SEDGE Ventures LLC

Seekyo Therapeutics

Serenatis Bio

Servier Ventures

Shanda Grab Ventures Limited

Sirona Capital

Skyvor Medical AG

Sobi

Sofinnova Partners SAS

Solgate GmbH

SPARK Finland

SpliceBio, S.L.

Staatz BD & Strategy

Stifel

Sunstone Life Science Ventures

Swiss Biotech Association

Synameta Therapeutics

TargImmune Therapeutics AG

TAXIS Pharmaceuticals, Inc.

Terra Quantum AG

The Fulford Group Ltd.

Therakles Pharmaceuticals AG

TheraVenture GmbH

TOLREMO Therapeutics AG

Tribune Therapeutics AB

Truffle Capital

TVM Capital Life Science

UBS AG

UCB Ventures

Umlaut.bio GmbH

Universite Paris-Saclay

University of Zurich

UPyTher B.V.

UZH Life Sciences Fund, AG

VALANX Biotech GmbH

Valor Management

VBW Holdings Inc

Versant Ventures

Vesalius Biocapital IV Partners SàRL

Vi Partners AG

Viopas Venture Consulting GmbH

VSP

VUS Genetics

Wellington Partners

WuXi AppTec

XGEN Venture SGR S.p.A

XGEN Venture SGR S.p.A.

XOventure

YAYA Capital

Zinc VC